A meta‐analysis and cost‐minimization analysis of bivalirudin versus heparin in high‐risk patients for percutaneous coronary intervention

This meta‐analysis was performed to compare the safety, efficacy, and pharmacoeconomic of bivalirudin versus heparin in high‐risk patients for percutaneous coronary interventions (PCI). Earlier meta‐analysis comparing bivalirudin and heparin during PCI demonstrated that bivalirudin caused less bleed...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Ke‐Xin, Cui, Bin, Cao, Shan‐Shan, Wang, Wen‐Jun, Yu, Feng, Wang, Jing‐Wen, Ding, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092421/
https://www.ncbi.nlm.nih.gov/pubmed/33939886
http://dx.doi.org/10.1002/prp2.774

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092421/
https://www.ncbi.nlm.nih.gov/pubmed/33939886
http://dx.doi.org/10.1002/prp2.774

Ejemplares similares